GPR183-IN-2 (compound 23) is a potent GPR183 inhibitor. GPR183-IN-2 inhibits Ca2+ mobilization with an IC50 value of 39.45 nM. GPR183-IN-2 has the potential for the research of cancer, autoimmune diseases, pain, and osteoporosis.
Pharmacokinetic Parameters[1].
References:
[1]. Jian Bei Xi, et al. Compounds and their use as GPR183 inhibitors. CN118201911A.